How is K4DD addressing the issue?

K4DD brings together a range of world class scientists within Europe who will jointly address the issues that hinder the routine study of drug-target binding kinetics. The researchers within the K4DD project are passionate about enhancing understanding and awareness of the underlying principles of drug-target binding kinetics and they will work hard to achieve this.

The overall aim of the K4DD project, supported by the Innovative Medicines Initiative (IMI), is to enable the adoption of drug-target binding kinetics analysis in the drug discovery decision-making process. This should ultimately lead to the development of a new generation of improved medicinal products. K4DD wants to achieve its goal by focusing on three main areas of research; so-called work packages (WPs):




K4DD meeting, Janssen, Beerse 25-26 November 2013
s